MDGSW
Income statement / Annual
Last year (2022), Medigus Ltd. WT C EXP 072323's total revenue was $91.86 M,
an increase of 807.87% from the previous year.
In 2022, Medigus Ltd. WT C EXP 072323's net income was -$10.21 M.
See Medigus Ltd. WT C EXP 072323,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$91.86 M |
$10.12 M |
$531.00 K |
$273.00 K |
$436.00 K |
$467.00 K |
$549.00 K |
$618.91 K |
$684.14 K |
$717.30 K |
| Cost of Revenue |
$77.41 M
|
$5.32 M
|
$1.03 M
|
$455.00 K
|
$607.00 K
|
$516.00 K
|
$176.00 K
|
$274.87 K
|
$321.53 K
|
$323.33 K
|
| Gross Profit |
$14.45 M
|
$4.80 M
|
-$503.00 K
|
-$182.00 K
|
-$171.00 K
|
-$49.00 K
|
$373.00 K
|
$344.04 K
|
$362.62 K
|
$393.97 K
|
| Gross Profit Ratio |
0.16
|
0.47
|
-0.95
|
-0.67
|
-0.39
|
-0.1
|
0.68
|
0.56
|
0.53
|
0.55
|
| Research and Development Expenses |
$4.85 M
|
$1.05 M
|
$997.00 K
|
$609.00 K
|
$1.81 M
|
$2.21 M
|
$3.66 M
|
$4.36 M
|
$3.70 M
|
$2.35 M
|
| General & Administrative Expenses |
$14.17 M
|
$9.96 M
|
$5.49 M
|
$13.18 M
|
$3.34 M
|
$3.01 M
|
$3.68 M
|
$2.83 M
|
$2.11 M
|
$1.97 M
|
| Selling & Marketing Expenses |
$4.01 M
|
$1.99 M
|
$471.00 K
|
$326.00 K
|
$1.35 M
|
$846.00 K
|
$2.13 M
|
$2.66 M
|
$2.15 M
|
$928.64 K
|
| Selling, General & Administrative Expenses |
$18.18 M
|
$11.95 M
|
$5.97 M
|
$13.51 M
|
$4.69 M
|
$3.85 M
|
$5.81 M
|
$5.49 M
|
$4.25 M
|
$2.90 M
|
| Other Expenses |
$45.00 K
|
$494.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$23.03 M
|
$13.00 M
|
$6.96 M
|
$14.11 M
|
$6.50 M
|
$6.06 M
|
$9.46 M
|
$9.85 M
|
$7.95 M
|
$5.25 M
|
| Cost And Expenses |
$100.44 M
|
$18.31 M
|
$8.00 M
|
$14.57 M
|
$7.11 M
|
$6.58 M
|
$9.64 M
|
$10.12 M
|
$8.27 M
|
$5.58 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$71.00 K
|
$99.00 K
|
$0.00
|
$30.82 K
|
$14.07 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$17.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.80 M
|
-$14.03 M
|
-$503.00 K
|
-$35.00 K
|
-$106.00 K
|
$77.00 K
|
$99.00 K
|
$121.17 K
|
$75.50 K
|
$120.60 K
|
| EBITDA |
-$11.99 M |
-$22.23 M |
-$7.89 M |
-$14.46 M |
-$6.78 M |
-$5.96 M |
-$9.02 M |
-$9.49 M |
-$8.68 M |
-$8.23 M |
| EBITDA Ratio |
-0.13
|
-2.2
|
-14.85
|
-52.95
|
-15.55
|
-12.76
|
-16.42
|
-15.33
|
-12.69
|
-11.47
|
| Operating Income Ratio |
-0.15
|
-0.81
|
-13.91
|
-52.82
|
-15.3
|
-13.08
|
-16.56
|
-15.35
|
-10.74
|
-6.51
|
| Total Other Income/Expenses Net |
$3.69 M
|
$12.35 M
|
$543.00 K
|
$241.00 K
|
$94.00 K
|
$3.56 M
|
$112.00 K
|
$88.38 K
|
$1.54 M
|
$3.20 M
|
| Income Before Tax |
-$10.10 M
|
$4.15 M
|
-$6.84 M
|
-$14.18 M
|
-$6.58 M
|
-$2.55 M
|
-$8.98 M
|
-$9.41 M
|
-$5.81 M
|
-$1.47 M
|
| Income Before Tax Ratio |
-0.11
|
0.41
|
-12.88
|
-51.94
|
-15.09
|
-5.46
|
-16.36
|
-15.21
|
-8.49
|
-2.04
|
| Income Tax Expense |
$111.00 K
|
$105.00 K
|
$9.00 K
|
-$1.00 K
|
$20.00 K
|
-$7.00 K
|
$28.00 K
|
$67.63 K
|
$3.34 K
|
$24.41 K
|
| Net Income |
-$10.21 M
|
$4.05 M
|
-$6.85 M
|
-$14.18 M
|
-$6.60 M
|
-$2.55 M
|
-$9.01 M
|
-$9.48 M
|
-$5.81 M
|
-$1.49 M
|
| Net Income Ratio |
-0.11
|
0.4
|
-12.9
|
-51.93
|
-15.13
|
-5.45
|
-16.41
|
-15.32
|
-8.49
|
-2.08
|
| EPS |
0 |
0.0088 |
-0.0513 |
-0.18 |
-0.16 |
0 |
0 |
0 |
0 |
0 |
| EPS Diluted |
0 |
0.0088 |
-0.0513 |
-0.18 |
-0.16 |
0 |
0 |
0 |
0 |
0 |
| Weighted Average Shares Out |
$0.00
|
$460.72 M
|
$133.45 M
|
$78.12 M
|
$41.99 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$0.00
|
$460.72 M
|
$133.45 M
|
$78.12 M
|
$41.99 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
